Premier Health Reports AMP Decision Regarding Subsidiaries in Quebec

Premier Health Reports AMP Decision Regarding Subsidiaries in Quebec

Premier Health of America Inc. (TSXV: PHA,OTC:PRHAF) (the " Company " or " Premier Health "), a leading Canadian health tech company, today announced that its subsidiaries, Code Bleu, Placement Premier Soin, Premier Health Nordik and Solutions Nursing (the "Quebec Subsidiaries"), have been notified by the Autorité des marchés publics (AMP) of their registration in the Register of Enterprises Ineligible for Public Contracts under the Act respecting contracting by public bodies (LCOP).

As previously disclosed, the Quebec Subsidiaries received advance notices from the AMP in February 2025, following which corrective measures were implemented by the Company to address the concerns raised.

As a result of the registration, the Quebec Subsidiaries are ineligible to enter public contracts or subcontracts for a period of five years from the date of registration and are granted a period of 60 days to cease the performance of ongoing public contracts, unless a specific authorization is obtained from Quebec's Treasury Board or Quebec's Minister of Municipal Affairs, as applicable. This ineligibility applies exclusively to public contracts in Quebec and does not affect the Company's activities in other jurisdictions or with private entities in Quebec.

The Company's public contracts in the province of Quebec represented 12% of total revenues for the last quarter ending June 30, 2025, and the Company is currently exploring all available options, including administrative and judicial remedies provided by law. The Company remains fully committed to upholding the highest standards of compliance and governance and will communicate any material developments in due course.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary LiPHe ® platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This press release contains forward-looking information within the meaning of applicable securities legislation which reflects the current plans and expectations of the Company with respect to future events and financial performance. All statements other than statements of historical or current facts may be forward-looking information. Forward-looking information includes statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as ‘believes', ‘continues', ‘expects', ‘projects', ‘anticipates', ‘plans', ‘estimates', ‘seeks', ‘intends', ‘targets', ‘forecasts', or negative or grammatical versions thereof and other similar expressions, or future or conditional verbs such as ‘may', ‘will', ‘should', ‘would' and ‘could'. Forward-looking information in this press release includes, but is not limited to, statements with respect to the strategic review process. Forward-looking information is based on management's plans, estimates, projections, beliefs and opinions as at the date of this release, and the assumptions related to those plans, estimates, projections, beliefs and opinions may change; therefore, they are presented for the purpose of assisting the Company's security holders in understanding management's views at such time regarding those future outcomes and may not be appropriate for other purposes. Although the forward-looking information contained in this release is based on assumptions which the Company believes are reasonable, there can be no assurance that actual results will be consistent with such forward-looking information. The forward-looking information in this release relate only to events or information as of the date on which the statements are made and, except as specifically required by applicable securities laws, the Company undertakes no obligation to update or revise publicly any forward-looking information, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. There can be no assurance that the forward-looking information will prove to be accurate. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Company with Canadian securities regulatory authorities available at www.sedarplus.ca


For Further Information Please Contact: Mr. Jean-Robert Pronovost Vice-President, Corporate Development Premier Health of America Inc. jrpronovost@premierhealth.ca / 1 800 231 9916

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PHA:CA
The Conversation (0)
Premier Health of America

Premier Health of America

Modernizing Healthcare Staffing with Automated, On-Demand Services

Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announced today that the TSX Venture Exchange (" TSXV ") has accepted the Corporation's application for its normal course issuer bid (the " NCIB ") for a portion of its... Keep Reading...
Premier Health Announces CFO Transition

Premier Health Announces CFO Transition

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, today announced that it is proceeding with a transition of the CFO functions and appoints Simon Belval as Interim Chief Financial Officer, effective immediately. Simon... Keep Reading...
Premier Health Reports FY2022 Third Quarter Results

Premier Health Reports FY2022 Third Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its third quarter ended June 30, 2022. Summary The Corporation had... Keep Reading...
Premier Health Reports FY2022 Second Quarter Results

Premier Health Reports FY2022 Second Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022. Summary The Corporation had... Keep Reading...
Premier Health of America

Premier Health Announces the Appointment of Giovanni Garay as Ontario General Manager

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announces the appointment of Giovanni Garay as Ontario General Manager, effective immediately. "We are very excited to have Giovanni join Premier Health. His hiring... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at... Keep Reading...
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the... Keep Reading...
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries CommenceDownload the PDF here. Keep Reading...

Latest Press Releases

Related News